Acne Medication Market Analysis

Acne Medication Market Analysis

Acne medication market from oral segment is expected to expand at over 6% CAGR between 2023 and 2032. Oral formulations are prescribed to reduce bacterial outgrowth and treat moderate to severe acne due to their high efficacy and better clinical outcomes. Oral therapeutics target acne-causing bacteria in and around the follicles to decrease sebum production and reduce inflammation. The increasing incidences of people suffering from severe and inflammatory acne manifested as nodules or cysts will drive segmental gains.
 

Acne medication market from retinoids segment was worth over USD 2.8 billion in 2022. Retinoids are found effective in treating moderate to severe acne, which has not responded well to other treatments. These products help prevent clogged pores and get rid of dead skin cells, thus enabling other topical formulations to work better. The high efficacy and versatility of retinoid pills in treating severe acne issues and reducing outbreaks will propel segment share.
 

Acne medication market from prescription segment amassed more than 54% business share in 2022 and is expected to record significant valuation by 2032. Prescription acne medications are recommended by dermatologists to control acne breakouts, minimize the prospects of scarring and skin damage, and reduce the visibility of scars. These include several oral antibiotic medicines and topical ointments & lotions containing salicylic acid, azelaic acids, benzoyl peroxide, retinoids, and others. The increasing utilization of a broad spectrum of prescription medications to get rid of severe acne and scar problems will drive the market statistics.
 

Acne medication market from inflammatory acne segment was valued at over USD 5.6 billion in 2022 and is predicted to garner appreciable gains through the forecast period. Inflammatory acne is a painful skin condition recognized by redness, swelling, and pores clogged with oil, bacteria, and dead skin cells. Several studies have addressed that acne may affect people's psychological well-being and can lead to conditions such as loss of self-identity, self-esteem, depression, anxiety, and suicidal tendency, bolstering the market share.
 

Acne medication market from pharmacies and drug store segment is expected to exhibit over 5.5% CAGR from 2023 to 2032 owing to the easy accessibility and expanding network of pharmacies and drug stores across several economies. Furthermore, an increasing number of pharmacies expanding their geographical footprints in remote locations will drive product sales.
 

Europe acne medication market is slated to garner more than USD 2.4 billion by 2032. This is attributed to the increasing acne-prone population, rising income levels, and the growing consciousness regarding the overall appearance among individuals. Besides, the availability of skilled dermatologists and the rise in expenditure on beauty and aesthetics will strengthen the regional market landscape.